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Abstract: Increased plasma free fatty acids (FFAs) are associated with cardiometabolic risk factors
in adults with abdominal obesity (AO). However, this association remains controversial in children.
This study analyzed plasma FFA concentration in children with and without AO. Twenty-nine
children classified with AO were matched by age and sex with 29 non-obese individuals. Blood
samples were collected after fasting for 10–12 h. Plasma concentration of glucose, insulin,
triglycerides, total cholesterol, low-density lipoprotein cholesterol (LDL-C), and high-density
lipoprotein cholesterol (HDL-C) were determined by automatized methods. FFAs were analyzed by
gas chromatography. Children with and without AO had similar age (7.1 ± 2.6 vs. 7.2 ± 2.7 years;
p > 0.05) but obese children showed higher (p < 0.05) body mass index (BMI) (+4.3 kg/m2), systolic
blood pressure (+5.1 mmHg), and insulin (+27.8 pmol/L). There were no significant differences in
plasma total FFA concentration between groups (1.02 ± 0.61 vs. 0.89 ± 0.37 mmol/L; p > 0.05).
However, children with AO had higher palmitoleic acid (0.94 vs. 0.70 wt %; p < 0.05) and
dihomo-gamma linoleic acid (DHGL) (2.76 vs. 2.07 wt %; p < 0.05). Palmitoleic and DHGL acids
correlated (p < 0.05) with BMI (r = 0.397; r = 0.296, respectively) and with waist circumference
(r = 0.380; r = 0.276, respectively). Palmitoleic acid correlated positively with systolic blood pressure
(r = 0.386; p < 0.05) and negatively with HDL-C (−0.572; p < 0.01). In summary, children with AO
have higher plasmatic concentrations of free palmitoleic and DHGL fatty acids, which correlate with
cardiometabolic risk factors.
Keywords: plasma free fatty acids profile; central obesity; waist circumference; cardiometabolic risk
factors; gas chromatography
1. Introduction
Abdominal obesity (AO) represents an increase in visceral and subcutaneous adipose tissue,
and it is associated with excessive chronic energy intake and a sedentary lifestyle [1–3]. AO is
a cardiovascular risk factor and a major predictor of the metabolic abnormalities observed in the
metabolic syndrome (e.g., dyslipidemia, high blood pressure, and impaired glucose metabolism) [4,5].
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Circulating concentrations of free fatty acids (FFAs) have been proposed to be a possible link between
abdominal obesity and cardiometabolic alterations [6,7]. According to the “fatty acids theory”,
hypertrophied insulin resistant adipocytes release excessive fatty acids (e.g., FFAs) to blood circulation.
This promotes ectopic lipid accumulation and insulin resistance in key organs (e.g., liver, pancreas,
heart, and skeletal muscle) and results in cardiometabolic alterations [7,8]. Data in adults show
associations of plasma FFAs with insulin resistance, metabolic syndrome, increased risk of type-2
diabetes, and other obesity-related metabolic disorders [9–12]. Despite the fact that childhood obesity
can trigger early development of cardiovascular diseases [13,14], there is limited research about the
relationship between FFAs and cardiometabolic risk factors in pediatric populations [15,16].
Studies comparing plasma FFA concentration in children with and without obesity show mixed
results. Sabin et al. [17] and Reinehr et al. [18] found higher concentrations of total FFAs in obese
children compared to normal weight peers. In contrast, Chu et al. [19] and Bermudez et al. [20]
did not find significant differences in total FFAs in obese children compared with normal weight
kids; and Gil-Campos et al. [21] reported lower total FFAs in obese children. Several reasons may
explain the contradictory results among studies, such as the inclusion of children at different pubertal
stages, the lack of control by age and gender in the analysis, and the use of the body mass index
(BMI) to classify obesity, since there is a high variability in the fat mass content for a given BMI in
youth [22,23]. Recently (2014), the Identification and prevention of dietary- and lifestyle-induced
health effects in children and infants-Study (IDEFICS) released waist circumference cut-offs obtained
from a representative sample from nine European countries [24]. These reference values derived from
normal-weight children offer a good option to classify AO in children [24].
Most studies in children only report the total FFA concentration [18,19,25–27]. However,
the FFA profile adds significant information given that different fatty acids might have diverse
metabolic effects [6,28]. The analysis of the FFA profile also allows to calculate the product–precursor
ratio of several fatty acids, such as palmitoleic/palmitic, dihomo-gamma-linoleic/linoleic,
and arachidonic/dihomo-gamma-linoleic, which are used to estimate delta-9, delta-5, and delta-6
desaturase activities, respectively [9,29]. Studies in adults showed that high activities of delta-9 and
delta-6, and low activity of delta-5, are related to insulin resistance and metabolic syndrome [9,29–31].
A better understanding of the role of FFAs in the relationship between AO and cardiovascular
risk factors may help to improve obesity prevention and treatment, an urgent task given the high
worldwide prevalence of childhood obesity. Studies in children may provide key information since
factors that affect FFA profile, such as smoking, alcohol intake, and medicament use, are better
controlled. Furthermore, at young ages the long-term effects of obesity are not fully established.
This study compared the FFA profile with estimated desaturase activities in children with and without
AO, and examined how FFAs and desaturase activities are associated with cardiovascular risk factors
and metabolic syndrome components.
2. Materials and Methods
This is a cross-sectional analytical study. A convenient subsample of 58 children from
Medellin-Colombia were selected from the South American Youth/Child Cardiovascular and
Environmental study (SAYCARE). SAYCARE is a running multicenter study in children and
adolescents attending private and public schools at seven South American cities. SAYCARE aims
to develop methods to collect reliable, comparable, and validated data about cardiovascular
health biomarkers, lifestyles, and environmental, social, and familial factors. Children who were
sick or under treatment with steroids or other kinds of hormones/medications were excluded.
Twenty-nine abdominal obese children (17 boys and 12 girls) were matched one by one according
to age and sex with non-abdominal obese peers. The group sample size was calculated with
a power of 85% (at 95% level of confidence), which allowed for the detection of a minimum
difference between groups of 4.1 µmol/L of myristic fatty acid, which has been previously reported in
children [17]. The study was performed according to the Helsinki Declaration and was approved by the
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Bioethical Review Board of the Research System from the University of Antioquia, Medellín-Colombia
(certificate number 14-43-596, 28 May 2014). Informed consent was obtained from all participants and
guardians of the children.
Abdominal obesity assessed by waist circumference, and the other metabolic syndrome
components (e.g., high blood pressure, low HDL-C concentrations, high triglyceride concentrations,
and glucose intolerance or insulin resistance) were evaluated using as a cut-off the 90th-percentile
reference value of the IDEFICS study [24,32,33].
Children’s parents/caregivers answered a semi-quantitative food frequency questionnaire (FFQ)
in an oral interview with registered dietitians. The FFQ was designed with 70 items, each one with
several answer options to capture the habitual food intake of the SAYCARE study participants.
The FFQ was designed to collect information of food intake related to cardiovascular diseases,
and was validated with multiple 24 h dietary recalls. The FFQ data were analyzed to estimate daily
energy and macronutrient intake using the Colombian food database as described by others [34,35].
Due to food database limitations, the analysis provided total grams of saturated, monounsaturated,
and polyunsaturated fat intake without specifying individual fatty acids.
Body weight was measured to the nearest 0.1 kg using a digital scale (WISO W801, Barreiros,
Brazil). Height was measured to the nearest 0.1 cm using a stadiometer (Cardiomed WSC, Paraná,
Brazil). Waist circumference was measured to the nearest 0.1 cm, midway between the lowest rib
margin and the iliac crest, using a flexible tape (Cardiomed WSC, Paraná, Brazil). Biceps, triceps,
subscapular, and iliocrestal skinfold thickness were measured on the right side of the body to the
nearest millimeter, using a caliper (Lange, CA, USA) as described by Lohman [36]. Triceps and
subscapular skinfolds were summed and the percentage of fat mass was calculated with Slaughter’s
equation [37].
Participants were instructed to fast overnight for 10 to 12 h. Blood was drawn from the antecubital
vein in ethylenediaminetetraacetic acid tubes. Blood was immediately centrifuged at 1500× g for 15 min
at 4 ◦C. Plasma was aliquoted and kept frozen at −80 ◦C for further analysis. Plasma glucose and lipid
profile were measured by colorimetric and enzymatic methods using an automatic analyzer (Roche,
Cobas c501, Mannheim, Germany). Insulin was measured by a chemiluminescence method using
an automatic analyzer (Roche, Cobas c501, Mannheim, Germany). High-sensitive C-reactive protein
(hs-CRP) was measured by a turbidimetric method using an automatic analyzer (Roche, Cobas c501,
Mannheim, Germany). The coefficients of variation for these essays were as follows: glucose: 1.1%;
insulin: 4.2%; triglycerides: 1.3%; total cholesterol: 1.2%; HDL-C: 1.6%; hs-CRP: 1.8%. HOMA-IR was
calculated as plasma glucose (mmol/L) × plasma insulin (mU/L)/22.5 [38].
Plasma lipids were extracted by the Folch method [39]. The free fatty acid fraction was
separated from plasma lipids using solid-phase extraction (SPE) by column chromatography
(SPE NH2 300 mg, Sigma-Aldrich, St. Louis, MO, USA). Fatty acids were methylated with
boron trifluoride (20% BF3-MeOH). The fatty acid methyl esters (FAMEs) were analyzed using
gas chromatography (Agilent Technologies 7890B GC system, Santa Clara, CA, USA). The FAMEs
were identified by comparison with authentic FAME standards and peak areas were integrated as
relative weight (wt %) using OpenLab CDS ChemStation software (Agilent Technologies, Santa Clara,
CA, USA). The coefficient of variation for the free fatty acid analysis was 1.3%. The product–precursor
ratio of the FFAs palmitoleic (16:1, n-7)/palmitic (16:0), dihomo-gamma-linoleic (20:3 n-6)/linoleic
(18:2 n-6), and arachidonic (20:4 n-6)/dihomo-gamma-linoleic (20:3 n-6) were used to estimate
adipocytes’ activities of delta-9 desaturase, delta-6 desaturase, and delta-5 desaturase, respectively,
as described by others [40,41].
Normal distribution of data was tested with the Kolmogorov–Smirnov test. Results are presented
as means ± standard deviation or median and interquartile range according to the normal distribution
of data. For normally distributed data, a t-test was used to test differences between non-obese and
abdominal obese children; one-way ANOVA with Scheffé post-hoc was used to test differences
between FFA concentrations, estimated desaturase activities and the metabolic syndrome components.
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For non-normally distributed data, Mann–Whitney and Kruskal–Wallis tests were used to compare
two or more groups, respectively. Partial correlations adjusted by sex and age were run between FFA
concentrations, estimated desaturase activities, and cardiometabolic factors. A p-value ≤ 0.05 was
considered statistically significant.
3. Results
Fifty-eight children (29 with AO and 29 without AO; 3 to 10 years) were included in the study.
There were 17 boys and 12 girls in each group, with a similar average age (7.1 ± 2.6 vs. 7.2 ± 2.7 years;
p = 0.876) (Table 1).
Table 1. Characteristics of participants by group 1.
Children without Abdominal
Obesity (n = 29)
Children with Abdominal
Obesity (n = 29) p-Value
Age (years) 7.1 ± 2.6 7.2 ± 2.7 0.876
Energy intake (kcal/day) 2453 ± 946 2358 ± 781 0.704
Carbohydrate intake (g/day) 307.8 ± 134.6 278.6 ± 92.4 0.374
Protein intake (g/day) 84.9 ± 30.7 92.4 ± 42.3 0.478
Saturated fat intake (g/day) 37.8 ± 15.1 37.5 ± 12.8 0.942
Monounsaturated fat intake (g/day) 40.1 ± 17.8 40.2 ± 14.5 0.975
Polyunsaturated fat intake (g/day) 15.5 ± 8.4 14.1 ± 5.6 0.488
Body height (cm) 118.8 ± 16.8 122.4 ± 16.7 0.424
Body weight (kg) 22.1 ± 6.0 30.9 ± 10.7 0.000 *
Body mass index (kg/m2) 15.4 (1.5) 19.7 (3.5) 0.000 †
Body mass index for age (z-score) −0.2 ± 0.7 1.9 ± 0.8 0.000 *
Waist circumference (cm) 53.7 (5.8) 64.9 (16.5) 0.000 †
Skinfolds Sum (mm) 26.5 (9.8) 60.5 (36.8) 0.000 †
Fat Percentage (%) 16.4 ± 5.5 26.1 ± 6.9 0.000 *
Systolic blood pressure (mmHg) 93.5 ± 6.4 98.6 ± 6.4 0.004 *
Diastolic blood pressure (mmHg) 58.5 ± 5.3 61.1 ± 6.5 0.096
Fasting blood glucose (mmol/L) 4.9 ± 0.3 4.8 ± 0.3 0.523
Fasting blood insulin (pmol/L) 42.4 (24.3) 70.2 (54.7) 0.032 †
HOMA-IR 1.3 (0.7) 2.2 (1.8) 0.051
Triglycerides (mmol/L) 0.77 (0.53) 0.87 (0.45) 0.363
Total cholesterol (mmol/L) 4.12 (1.26) 3.97 (1.15) 0.363
HDL-C (mmol/L) 1.4 ± 0.3 1.3 ± 0.3 0.051
LDL-C (mmol/L) 2.3 ± 0.7 2.5 ± 0.7 0.246
Total FFAs (mmol/L) 1.02 (0.61) 0.89 (0.37) 0.258
Hs-CRP (nmol/L) 11.0 (7.8) 16.6 (14.2) 0.016 †
1 Data presented as mean ± standard deviation or medians and interquartile range in parentheses according to the
data distribution. * Differences between groups obtained with independent t-test. † Differences between groups
obtained with the Mann–Whitney test. HOMA-IR: homeostasis model assessment of insulin resistance; HDL-C:
high-density lipoprotein cholesterol; FFAs: free fatty acids; hs-CRP: high-sensitive C-reactive protein.
There were no significant differences in energy or macronutrient intake between groups with and
without AO. As expected, abdominal obese children compared with non-obese peers showed higher
(p < 0.001) BMI (+4.3 kg/m2), waist circumference (+11.2 cm), skinfold thickness sum (+34.0 mm),
and body fat percentage (+9.7%). In addition, the obese group had higher systolic blood pressure
(+5.1 mmHg; p = 0.001), fasting insulin (+27.8 pmol/L; p = 0.032), and high sensitive C-reactive protein
(hs-CRP +5.6 nmol/L; p = 0.016) (Table 1).
The FFA profile and estimated desaturase activities are presented in Table 2. Abdominal obese
children showed a higher concentration of palmitoleic acid (+0.24 wt %; p = 0.038) and DHGL acid
(+0.69 wt %; p = 0.015). Likewise, the obese group had higher estimated activity of delta-9 desaturase
(+0.01; p = 0.010) and delta-6 desaturase (+0.04; p = 0.010) and a lower activity of delta-5 desaturase
(−0.94; p = 0.010) (Table 2).
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Table 2. Plasma free fatty acid proportions in children with and without abdominal obesity 1
Children without
Abdominal Obesity
Children with
Abdominal Obesity p-Value
Saturated fatty acids 42.77 ± 3.69 43.44 ± 3.63 0.485
Myristic (14:0) ‡ 0.65 ± 0.23 0.67 ± 0.20 0.865
Palmitic (16:0) 26.32 ± 3.06 27.09 ± 3.39 0.365
Estearic (18:0) 16.02 ± 1.24 15.96 ± 1.24 0.858
Monounsaturated fatty acids 25.88 ± 11.30 25.26 ± 8.95 0.819
Palmitoleic (16:1 n-7) ‡ 0.70 ± 0.29 0.94 ± 0.35 0.038 *
Oleic (18:1 n-9) 25.47 ± 11.33 24.71 ± 8.90 0.778
Polyunsaturated fatty acids 31.34 ± 8.00 31.28 ± 5.94 0.974
Linoleic (18:2 n-6) 19.72 ± 4.04 19.23 ± 3.97 0.603
DHGL (20:3 n-6) 2.07 ± 0.98 2.76 ± 1.09 0.015 *
Arachidonic (20:4 n-6) 6.75 ± 2.05 6.96 ± 2.35 0.729
DHA (22:6 n-3) 2.79 ± 1.80 2.34 ± 0.83 0.221
Fatty acids ratios
16:1 n-7/16:0 (D9) ‡ 0.03 ± 0.01 0.04 ± 0.01 0.010 *
20:3 n-6/18:2 n-6 (D6) 0.10 ± 0.04 0.14 ± 0.06 0.002 *
20:4 n-6/20:3 n-6 (D5) 3.47 (1.69) 2.53 (0.63) 0.002 †
Omega-6/Omega-3 12.76 ± 4.55 13.64 ± 3.65 0.406
1 Data presented as mean ± standard deviation or medians and interquartile range in parentheses according
to the data distribution. * Differences between groups obtained with independent t-test. † Differences between
groups obtained with the Mann–Whitney test. ‡ Abdominal obese children n = 18, children without abdominal
obesity n = 19. DHGL: dihomo-gamma-linoleic acid; DHA: docoxahexanoic acid; D9: delta-9 desaturase; D6: delta-6
desaturase; D5: delta-5 desaturase.
Selected correlation coefficients of anthropometric and cardiometabolic variables with FFAs and
desaturase activities are presented in Table 3. Waist circumference and BMI showed similar patterns;
they correlated positively with palmitoleic acid, DHGL acid, delta-9 desaturase, and delta-6 desaturase;
conversely, they correlated negatively with delta-5 desaturase (Table 3). HDL-C correlated negatively
with palmitoleic acid (r = −0.572; p < 0.01) and delta-9 desaturase (r = −0.540; p < 0.01). Systolic
blood pressure showed weak but significant correlations with palmitic, palmitoleic, and DHGL acids,
and it correlated with delta-9, delta-6, and delta-5 desaturases. Other weak correlations of fat mass
percentage and insulin with FFAs and desaturases are shown in Table 3.
Table 3. Selected correlation coefficients of anthropometric and cardiometabolic variables with free
fatty acids and estimated desaturase activities.
Anthropometric and
Cardiometabolic
Palmitic
(16:0)
Palmitoleic
(16:1 n-7)
DHGL
(20:3 n-6)
16:1
n-7/16:0 (D9)
20:3 n-6/18:2
n-6 (D6)
20:4 n-6/20:3
n-6 (D5)
Body mass index 0.145 0.397 * 0.296 * 0.451 * 0.342 * −0.299 *
Waist circumference 0.160 0.380 * 0.276 * 0.414 * 0.332 * −0.302 *
Fat mass percentage 0.146 0.338 0.232 0.403 * 0.289 * −0.242
Systolic blood pressure 0.265 * 0.386 * 0.330 * 0.368 * 0.284 * −0.314 *
Insulin −0.014 0.272 0.132 0.306 0.142 −0.281 *
HDL-C −0.164 −0.572 ** −0.198 −0.540 ** −0.250 0.242
Correlations in the whole group (n = 58) and adjusted by sex and age. * p < 0.05; ** p < 0.01. HDL-C: high-density
lipoprotein cholesterol. DHGL: dihomo-gamma-linoleic acid; D9: delta-9 desaturase; D6: delta-6 desaturase; D5:
delta-5 desaturase.
Estimated delta-6 and delta-5 desaturase activities were related to the metabolic syndrome
components (Figure 1). Children who had one or more metabolic syndrome components showed
lower delta-5 desaturase activity. In addition, children who had two or more metabolic syndrome
components showed higher delta-6 desaturase activity (Figure 1).
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Figure 1. Estimated activities of delta-5 desaturase (a) and delta-6 desaturase (b) according to the 
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comparison. * Different from zero components p < 0.05. 
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Although no differences were found in total FFA concentration between groups, abdominal obese 
children showed differences in the plasma free fatty acid profile and estimated desaturase activities. 
Furthermore, some plasma FFAs correlated with cardiometabolic risk factors, suggesting that AO 
affects the FFA profile even at young ages. 
Plasma total FFA concentrations did not differ between children with and without AO, and the 
groups’ values were similar to those reported in the literature between 0.332 and 1.02 mmol/L [17,25,27]. 
According to the “fatty acid theory”, obesity induces insulin resistance in adipocytes, triggering 
higher lipolysis rate and increased fatty acid release; these alterations augment FFA concentration in 
blood [7,8]. Several reasons may exist to explain the lack of higher total FFA concentration in obese 
kids: (a) abdominal obese children may have a normal insulin-response with respect to inhibition of 
lipolysis, as it has been described in obese adults [42,43]; (b) the elevated insulin concentration in 
obese kids (median = 70.2 pmol/L) may have prevented a raise in adipose tissue lipolysis; and (c) 
probably, children with AO did not present insulin resistance at this early age (3 to 10 years), given 
that their HOMA value (2.2) is still lower than the cut-off for insulin resistant (≥3.1). It is important to 
note that, in adolescents and adults, significant and positive associations have been observed 
between abdominal obesity, insulin resistance, and FFA concentrations [8,15,20,44]. 
Obese children showed higher concentrations of plasma non-esterified palmitoleic fatty acid. 
Palmitoleic acid mainly originates from de novo lipogenesis that occurs primarily in the liver and 
secondarily in the adipose tissue where this fatty acid is stored [45,46]. The higher concentration of 
palmitoleic acid in obese children may be due to a larger deposit in adipocytes, given that adipose 
tissue lipolysis is the major source of plasma FFAs at fasting state [40]. This idea is supported by the 
findings of Gong et al. [47], who reported higher concentrations of palmitoleic acid in adipose tissue 
of obese adults. Furthermore, in this study, obese children showed higher estimated delta-9 
desaturase activity and fasting insulin concentration. Delta-9 desaturase originates palmitoleic acid 
by desaturation of palmitic acid in a key regulatory step of lipogenesis, a process highly stimulated 
by insulin and carbohydrate intake [45]. Nevertheless, no significant differences in carbohydrate 
intake were found between obese and non-obese children, probably due to inaccuracy of the FFQ [48]. In 
adults, in several lipids fractions, palmitoleic acid and delta-9 desaturase activity have been 
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Figure 1. Estimated activities of delta-5 desaturase (a) and delta-6 desaturase (b) according to the
metabolic syndrome components. The Kruskal–Wallis test for differences of Delta-5 desaturase and
Delta-6 desaturase by metabolic syndrome components, with the Mann–Whitney Test for multiple
comparison. * Different from zero components p < 0.05.
4. Discussion
This study compared plasma FFA concentration with estimated desaturase activities in children
with and without AO, and explored the associations between FFAs and cardiometabolic risk factors.
Alt ough no differences were found in total FFA concentration between groups, abdominal obese
child en sh wed differences in the plasma free fatty acid profile and estimated desaturase activities.
Furthermore, some p asma FFAs correlated with cardiometabolic risk factors, suggesting that AO
affects the FFA profile eve at young ages.
Pla m total FFA concentrations did not diff r betwe n children with and without AO, and the
groups’ values were similar to those reported in the literature between 0.332 a d 1.02 mmol/L [17,25,27].
According to the “fatty acid theory”, obesity induces insulin resistance in adipocytes, triggering
higher lipolysis rate and increased fatty acid release; these alterations augment FFA concentration in
blood [7,8]. Several reasons may exist to explain the lack of higher total FFA concentration in obese
kids: (a) abdominal obese children may have a normal insulin-response with respect to inhibition of
lipolysis, as it has been described in obese adults [42,43]; (b) the elevated insulin concentration in obese
kids (median = 70.2 pmol/L) may have prevented a raise in adipose tissue lipolysis; and (c) probably,
children with AO did not present insulin resistance at this early age (3 to 10 years), given that their
HOMA value (2.2) is still lower than the cut-off for insulin resistant (≥3.1). It is important to note that,
in adolescents and adults, significant and positive associations have been observed between abdominal
obesity, insulin resistance, and FFA concentrations [8,15,20,44].
Obese children showed higher concentrations of plasma non-esterified palmitoleic fatty acid.
Palmitoleic acid mainly originates from de novo lipogenesis that occurs primarily in the liver and
secondarily in the adipose tissue where this fatty acid is stored [45,46]. The higher concentration of
palmitoleic acid in obese children may be ue to a larger deposit in adipocytes, given th t adipose tissue
lip lysis is the major source of plasma FFAs at fasting state [40]. This idea is supported by the findings
of Gong et al. [47], who reported higher concentrations of palmitoleic acid in adipose tissu of obese
adults. Furthermore, in th s study, obes children showed higher stimated delta-9 desaturase activity
and fasting insulin concentration. Delta-9 desaturase originates palmitoleic acid by desatur tion
of palmitic acid in a key regulatory step of lipogenesis, a process highly stimulated by insulin and
carbohydrate intake [45]. Nevertheless, no significant differences in carbohydrate intake were found
between obese and non-obese children, probably due to inaccuracy of the FFQ [48]. In adults, in several
lipids fractions, palmitoleic acid and delta-9 desaturase activity have been associated with increased
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risk of obesity, dyslipidemia, and insulin resistance [11,49–52]. This study found positive correlations
of palmitic acid and delta-9 estimated desaturase activity with BMI, waist circumference, and systolic
blood pressure, and negative correlations with HDL-C (Table 3).
Plasma non-esterified DHGL fatty acid concentrations were higher in obese children, and a similar
result was reported in a previous study [20]. This is probably due to the endogenous metabolism of
DHGL acid, since there were no differences in dietary PUFA intake, and DHGL acid is derived from
the essential linoleic fatty acid [52]. Furthermore, the estimated activity of delta-6 desaturase—the
rate-limiting enzyme in the production of DHGL from linoleic acid—was higher in obese children,
probably stimulated by the hyperinsulinemia. Similar to a study evaluating obese adolescents, DHGL
fatty acid was significantly correlated with BMI and waist circumference [20], and delta-6 desaturase
activity was positively associated with the number of metabolic syndrome components (Figure 1).
In obese children, the plasma FFA ratio of 20:3 n-6/18:2 n-6 was higher and that of 20:4 n-6/20:3 n-6
was lower. These FFA ratios have been suggested to reflect delta-6 and delta-5 desaturase activities in
adipocytes [40,41]. As mentioned before, the higher estimated delta-6 activity in obese children is probably
due to higher insulin values, but delta-5 desaturase may not respond so strongly to environmental effects
and may have a more genetic regulation [41]. Obese children showed low-grade systemic inflammation
(median hs-CRP = 1.8 mg/L) and lower delta-5 desaturase activity, which could be part of a mechanism to
avoid worsening the inflammatory state. Delta-5 desaturase uses DHGL acid to originate arachidonic acid
(ARA), and these fatty acids are competitive substrates for the cyclooxygenase enzyme (COX) [52]. COX
metabolites from DHGL acid are anti-inflammatory, and ARA metabolites are pro-inflammatory [52].
Therefore, keeping a low delta-5 activity in adipose tissue may help to downregulate ARA production
and inflammation when the levels of DHGL are increased, as they are in obese kids. This theory could
explain the negative correlation found between delta-5 desaturase activity and the number of metabolic
syndrome components (Figure 1), given the close connection between low-grade inflammation and
metabolic syndrome development.
To the best of our knowledge, this study is unique comparing plasma FFA concentration between
children with and without AO paired by age and sex. An additional strength of this study is the
use of specific sex and age cut-offs for waist circumference to classify AO. The IDEFICS references
values showed to be a good option for this end, given that obese children showed higher systolic blood
pressure, insulin concentrations, and hs-CRP levels and differed in the plasma FFA profile. The study
has some limitations: the cross-sectional design does not permit determining causality. Moreover,
the children age range (3–10 years) probably included kids with differences in habitual food intake and
lifestyle. To control for these variables, and possible differences in pubertal status, the groups with
and without AO were matched one by one according to age and sex. In addition, insulin resistance
was estimated by HOMA; however, there are better methods like the oral glucose tolerance test and
the intravenous glucose tolerance test. Similarly, waist circumference was used to establish AO,
where techniques like the dual X-ray densitometry and magnetic resonance imaging are more precise.
Nonetheless, we use waist circumference and HOMA because they provide acceptable information of
AO and insulin resistance, respectively [5,53–55]. In addition, they are practical methods, easier to be
accepted by the parents of our young participants than more invasive techniques. There are limitations
for the FFQ application; for example, some foods might have been missed, since the FFQ relies on
responders’ memories and some food items may not be listed in the instrument. The food database
limitations did not allow for an estimated dietary intake of individual fatty acids in order to analyze
how dietary fatty acids associate with the plasma FFA profile and the metabolic syndrome components.
5. Conclusions
Children with AO, compared to non-obese peers, showed higher systolic blood pressure, insulin
concentrations, and hs-CRP levels, but no differences in total FFA concentration. However, abdominal
obese kids had differences in the plasma FFA profile and estimated desaturase activities. Furthermore,
Nutrients 2018, 10, 31 8 of 11
some plasma FFAs were correlated with cardiometabolic risk factors, suggesting that AO affects the
FFA profile even at young ages.
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